ADHD affects about 5–7% of children and adolescents and 2–5% of adults. Although it is generally considered a childhood disorder, symptoms persist into adulthood for the majority of those affected. Medication remains a cornerstone of treatment, with stimulants considered the standard of care. However, non-stimulant therapies remain important alternatives.
Autoren
- Aneta Dehn
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- The AMALFI study and the limits of digital screening for atrial fibrillation
Remote monitoring for atrial fibrillation: lots of detection, little stroke prevention?
- MASH
Pharmacotherapies as “Game Changers”—What Are the Upcoming Challenges?
- Obesity Treatment
Oral GLP-1 Therapies: ATTAIN-1 and OASIS-4—The Next Leap Forward
- Older patients with atopic dermatitis
Why the Use of Biologics Is Recommended
- Disorders of the Gut-Brain Interaction
Peppermint-Caraway Oil Supplement Proves Effective in Phase IV Trial
- Gepante for Migraines
Relief from pain, symptoms, and improved functional ability—both acute and preventive
- Why the Finerenon Boom Is Giving Hyperkalemia Treatment New Relevance
Potassium binders as enablers of RAASi optimization
- Asthma in Adults: Bronchodilation and Anti-Inflammatory Therapy